Search Results - "HAYASHI, Ryoji"

Refine Results
  1. 1

    Cu Doping of CdTe Layers in Polycrystalline CdTe Thin-Film Solar Cells for Top Cells of Multijunction Solar Cells by Okamoto, Tamotsu, Hayashi, Ryoji, Hara, Shigeki, Ogawa, Yohei

    Published in Japanese Journal of Applied Physics (01-10-2013)
    “…The Cu doping of CdTe layers in CdTe solar cells without using a Cu-doped carbon electrode was investigated in order to develop transparent back contacts for…”
    Get full text
    Journal Article
  2. 2

    Pharmacologically distinct phenotypes of α1B‐adrenoceptors: variation in binding and functional affinities for antagonists by Yoshiki, Hatsumi, Uwada, Junsuke, Anisuzzaman, Abu Syed Md, Umada, Hidenori, Hayashi, Ryoji, Kainoh, Mie, Masuoka, Takayoshi, Nishio, Matomo, Muramatsu, Ikunobu

    Published in British journal of pharmacology (01-11-2014)
    “…Background and Purpose The pharmacological properties of particular receptors have recently been suggested to vary under different conditions. We compared the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Effects of Antimony Doping in Polycrystalline CdTe Thin-Film Solar Cells by Okamoto, Tamotsu, Ikeda, Shigeyuki, Nagatsuka, Satsuki, Hayashi, Ryoji, Yoshino, Kaoru, Kanda, Yohei, Noda, Akira, Hirano, Ryuichi

    Published in Japanese Journal of Applied Physics (01-10-2012)
    “…The effects of antimony (Sb) doping of the CdTe layer in the CdTe solar cells were investigated using Sb-doped CdTe powders as source materials for CdTe…”
    Get full text
    Journal Article
  5. 5

    Synthesis of novel IP agonists via N-aminoethyl cyclic amines prepared by decarboxylative ring-opening reactions by Morita, Yasuhiro, Ishigaki, Takeshi, Kawamura, Kuniaki, Hayashi, Ryoji, Isogaya, Masafumi, Kitsukawa, Mika, Miyamoto, Mitsuko, Uchida, Masashi, Iseki, Katsuhiko

    Published in Molecules (Basel, Switzerland) (31-01-2012)
    “…An efficient synthesis of a highly potent and selective IP (PGI(2) receptor) agonist that is not structurally analogous to PGI(2) is described. This synthesis…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Organic Anion-Transporting Polypeptide (OATP)-Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver by Uchida, Masashi, Tajima, Yoriko, Kakuni, Masakazu, Kageyama, Yutaka, Okada, Taro, Sakurada, Eri, Tateno, Chise, Hayashi, Ryoji

    Published in Drug metabolism and disposition (01-01-2018)
    “…The influence of transporters on the pharmacokinetics of drugs is being increasingly recognized, and DDIs via transporters may be a risk factor for adverse…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Fabrication of polycrystalline CdTe thin-film solar cells using carbon electrodes with carbon nanotubes by Okamoto, Tamotsu, Hayashi, Ryoji, Ogawa, Yohei, Hosono, Aikyo, Doi, Makoto

    Published in Japanese Journal of Applied Physics (01-04-2015)
    “…The effects of adding carbon nanotubes (CNTs) to carbon back electrodes in polycrystalline CdTe thin-film solar cells were investigated. The CNTs were prepared…”
    Get full text
    Journal Article
  13. 13

    Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists by Hayashi, Ryoji, Ohmori, Eiji, Moriwaki, Mitsuhiro, Kumagai, Hiroki, Isogaya, Masafumi

    Published in Bioorganic & medicinal chemistry letters (15-09-2015)
    “…[Display omitted] A series of novel indolylpiperidine derivatives were synthesized, and their pharmacological profiles were assessed at rat α1A and α1B…”
    Get full text
    Journal Article
  14. 14

    Piperidine derivatives as nonprostanoid IP receptor agonists by Hayashi, Ryoji, Sakagami, Hideki, Koiwa, Masakazu, Ito, Hiroaki, Miyamoto, Mitsuko, Isogaya, Masafumi

    Published in Bioorganic & medicinal chemistry letters (01-05-2016)
    “…[Display omitted] The discovery of a new class of nonprostanoid prostaglandin I2 receptor (IP receptor) agonists is reported. Among them, the unique piperidine…”
    Get full text
    Journal Article
  15. 15

    Piperidine derivatives as nonprostanoid IP receptor agonists 2 by Hayashi, Ryoji, Ito, Hiroaki, Ishigaki, Takeshi, Morita, Yasuhiro, Miyamoto, Mitsuko, Isogaya, Masafumi

    Published in Bioorganic & medicinal chemistry letters (15-06-2016)
    “…[Display omitted] We searched for a strong and selective nonprostanoid IP agonist bearing piperidine and benzanilide moieties. Through optimization of…”
    Get full text
    Journal Article
  16. 16

    The discovery of potent glycine transporter type-2 inhibitors: Design and synthesis of phenoxymethylbenzamide derivatives by Takahashi, Eiki, Arai, Tadamasa, Akahira, Masato, Nakajima, Mayumi, Nishimura, Kazumi, Omori, Yu, Kumagai, Hiroki, Suzuki, Tomohiko, Hayashi, Ryoji

    Published in Bioorganic & medicinal chemistry letters (15-09-2014)
    “…[Display omitted] We describe the discovery of phenoxymethylbenzamide derivatives as a novel class of glycine transporter type-2 (GlyT-2) inhibitors. We found…”
    Get full text
    Journal Article
  17. 17

    Identification of alpha-substituted acylamines as novel, potent, and orally active mGluR5 negative allosteric modulators by Yoshikawa, Keita, Ohyama, Tomofumi, Takahashi, Eiki, Numajiri, Yoshitaka, Konno, Mitsuhiro, Moriyama, Masaki, Takemi, Natsumi, Kunita, Kana, Nishimura, Kazumi, Hayashi, Ryoji

    Published in Bioorganic & medicinal chemistry letters (15-08-2015)
    “…[Display omitted] This Letter describes the identification of a series of novel non-acetylenic mGluR5 negative allosteric modulators based on the…”
    Get full text
    Journal Article
  18. 18

    Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives by Suzuki, Shinya, Okano, Tsubasa, Horiuchi, Rie, Hareyama, Nana, Amikura, Kazutoshi, Yamamoto, Naoyoshi, Yoshizawa, Yoshitaka, Yagi, Mai, Serizawa, Kanako, Hayashi, Ryoji

    Published in Bioorganic & medicinal chemistry letters (15-08-2015)
    “…[Display omitted] We aimed to create a novel and potent α1L-adrenoceptor agonist because such agonists are possible drug candidates for stress urinary…”
    Get full text
    Journal Article
  19. 19
  20. 20